Works matching IS 13406868 AND DT 2024 AND VI 31 AND IP 5

Results: 24
    1
    2

    Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers.

    Published in:
    Breast Cancer (13406868), 2024, v. 31, n. 5, p. 988, doi. 10.1007/s12282-024-01612-3
    By:
    • Hosonaga, Mari;
    • Habano, Eri;
    • Arakawa, Hiromi;
    • Kaneko, Keika;
    • Nakajima, Takeshi;
    • Hayashi, Naomi;
    • Fukada, Ippei;
    • Nakamura, Akira;
    • Haruyama, Yurie;
    • Maeda, Tetsuyo;
    • Inari, Hitoshi;
    • Kobayashi, Takayuki;
    • Nakashima, Eri;
    • Ueno, Takayuki;
    • Takano, Toshimi;
    • Takahashi, Shunji;
    • Ohno, Shinji;
    • Ueki, Arisa
    Publication type:
    Article
    3
    4

    The effect of exercise and educational programs for breast cancer patients on the development of breast cancer-related lymphoedema: secondary endpoint from a randomized controlled trial in the Setouchi Breast Project-10.

    Published in:
    Breast Cancer (13406868), 2024, v. 31, n. 5, p. 969, doi. 10.1007/s12282-024-01610-5
    By:
    • Nakamoto, Shogo;
    • Iwamoto, Takayuki;
    • Taira, Naruto;
    • Kajiwara, Yukiko;
    • Kawada, Kengo;
    • Takabatake, Daisuke;
    • Miyoshi, Yuichiro;
    • Kubo, Shinichiro;
    • Suzuki, Yoko;
    • Yamamoto, Mari;
    • Ogasawara, Yutaka;
    • Hatono, Minami;
    • Yoshitomi, Seiji;
    • Hara, Kyoko;
    • Sasahara, Asako;
    • Ohsumi, Shozo;
    • Ikeda, Masahiko;
    • Doihara, Hiroyoshi;
    • Mizota, Yuri;
    • Yamamoto, Seiichiro
    Publication type:
    Article
    5
    6
    7

    Prognosis of isolated locoregional recurrence after early breast cancer with immediate breast reconstruction surgery: a retrospective multi‑institutional study.

    Published in:
    Breast Cancer (13406868), 2024, v. 31, n. 5, p. 935, doi. 10.1007/s12282-024-01607-0
    By:
    • Seki, Hirohito;
    • Ogiya, Akiko;
    • Nagura, Naomi;
    • Shimo, Ayaka;
    • Narui, Kazutaka;
    • Sasada, Shinsuke;
    • Ishitobi, Makoto;
    • Nogi, Hiroko;
    • Kondo, Naoto;
    • Sakurai, Teruhisa;
    • Yamauchi, Chikako;
    • Mori, Hiroki;
    • Saiga, Miho;
    • Niikura, Naoki;
    • Shien, Tadahiko
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14

    Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study.

    Published in:
    Breast Cancer (13406868), 2024, v. 31, n. 5, p. 858, doi. 10.1007/s12282-024-01600-7
    By:
    • Yamashita, Toshinari;
    • Sohn, Joo Hyuk;
    • Tokunaga, Eriko;
    • Niikura, Naoki;
    • Park, Yeon Hee;
    • Lee, Keun Seok;
    • Chae, Yee Soo;
    • Xu, Binghe;
    • Wang, Xiaojia;
    • Im, Seock-Ah;
    • Li, Wei;
    • Lu, Yen-Shen;
    • Aguilar, Cecilia Orbegoso;
    • Nishijima, Soichiro;
    • Nishiyama, Yuji;
    • Sugihara, Masahiro;
    • Modi, Shanu;
    • Tsurutani, Junji
    Publication type:
    Article
    15
    16

    Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status.

    Published in:
    Breast Cancer (13406868), 2024, v. 31, n. 5, p. 886, doi. 10.1007/s12282-024-01603-4
    By:
    • Telli, Melinda L.;
    • Litton, Jennifer K.;
    • Beck, J. Thaddeus;
    • Jones, Jason M.;
    • Andersen, Jay;
    • Mina, Lida A.;
    • Brig, Raymond;
    • Danso, Michael;
    • Yuan, Yuan;
    • Symmans, William F.;
    • Hopkins, Julia F.;
    • Albacker, Lee A.;
    • Abbattista, Antonello;
    • Noonan, Kay;
    • Mata, Marielena;
    • Laird, A. Douglas;
    • Blum, Joanne L.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24